Eisai Co. Ltd
Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. It also offers prescription medicines. In addition, the company focuses on neurology and oncology and therapeutic areas. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headqua… Read more
Eisai Co. Ltd (ESALF) - Total Assets
Latest total assets as of December 2025: $1.49 Trillion USD
Based on the latest financial reports, Eisai Co. Ltd (ESALF) holds total assets worth $1.49 Trillion USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Eisai Co. Ltd - Total Assets Trend (2000–2025)
This chart illustrates how Eisai Co. Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Eisai Co. Ltd - Asset Composition Analysis
Current Asset Composition (March 2025)
Eisai Co. Ltd's total assets of $1.49 Trillion consist of 52.5% current assets and 47.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 19.2% |
| Accounts Receivable | $220.02 Billion | 15.9% |
| Inventory | $215.91 Billion | 15.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $75.26 Billion | 5.4% |
| Goodwill | $233.44 Billion | 16.8% |
Asset Composition Trend (2000–2025)
This chart illustrates how Eisai Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Eisai Co. Ltd's current assets represent 52.5% of total assets in 2025, a decrease from 64.3% in 2000.
- Cash Position: Cash and equivalents constituted 19.2% of total assets in 2025, up from 10.1% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, an increase from 1.0% in 2000.
- Asset Diversification: The largest asset category is goodwill at 16.8% of total assets.
Eisai Co. Ltd Competitors by Total Assets
Key competitors of Eisai Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Eisai Co. Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Eisai Co. Ltd generates 0.57x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Eisai Co. Ltd generates $ 3.35 in net profit.
Eisai Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.17 | 1.99 | 2.02 |
| Quick Ratio | 1.54 | 1.45 | 1.69 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $453.60 Billion | $ 2.41 Billion | $ 261.87 Billion |
Eisai Co. Ltd - Advanced Valuation Insights
This section examines the relationship between Eisai Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.33 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -0.5% |
| Total Assets | $1.39 Trillion |
| Market Capitalization | $7.09 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Eisai Co. Ltd's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Eisai Co. Ltd's assets decreased by 0.5% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Eisai Co. Ltd (2000–2025)
The table below shows the annual total assets of Eisai Co. Ltd from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | $1.39 Trillion | -0.52% |
| 2024-03-31 | $1.39 Trillion | +10.33% |
| 2023-03-31 | $1.26 Trillion | +1.94% |
| 2022-03-31 | $1.24 Trillion | +13.70% |
| 2021-03-31 | $1.09 Trillion | +2.62% |
| 2020-03-31 | $1.06 Trillion | -0.88% |
| 2019-03-31 | $1.07 Trillion | +2.14% |
| 2018-03-31 | $1.05 Trillion | +1.77% |
| 2017-03-31 | $1.03 Trillion | +5.83% |
| 2016-03-31 | $973.99 Billion | -7.58% |
| 2015-03-31 | $1.05 Trillion | +8.21% |
| 2014-03-31 | $973.82 Billion | -1.66% |
| 2013-03-31 | $990.25 Billion | -1.43% |
| 2012-03-31 | $1.00 Trillion | -3.98% |
| 2011-03-31 | $1.05 Trillion | -5.05% |
| 2010-03-31 | $1.10 Trillion | -4.03% |
| 2009-03-31 | $1.15 Trillion | +2.16% |
| 2008-03-31 | $1.12 Trillion | +41.89% |
| 2007-03-31 | $792.11 Billion | +6.01% |
| 2006-03-31 | $747.23 Billion | +12.75% |
| 2005-03-31 | $662.71 Billion | +7.62% |
| 2004-03-31 | $615.78 Billion | +4.07% |
| 2003-03-31 | $591.72 Billion | +6.12% |
| 2002-03-31 | $557.61 Billion | +1.49% |
| 2001-03-31 | $549.44 Billion | +13.13% |
| 2000-03-31 | $485.67 Billion | -- |